Trade Estonia expands business mission in UAE

Dubai: Seeking to further promote Estonia’s soft power and shed light on its progressive workforce, Trade Estonia will continue to build foundational relations with the United Arab Emirates by attending the 2023 editions of Arab Health, the MENA region’s leading exhibition for the laboratory industry taking place from 30 January 2023 – 2 February 2023 in Dubai, and Medlab Middle East, an exhibition offering a platform to conduct medical laboratory business in the Middle East taking place physically in Dubai from 6 – 9 February 2023 and virtually from 16 January 2023 – 9 March 2023.

In attendance will be 10 Estonian biotechnology companies, including Migrevention, the first fully digital headache clinic in the world, and Triumf Health, which offers evidence-based behavioural therapeutics for children aged 7 -12 through a mobile game to improve their mental well-being and quality of life.

Migrevention
Migrevention is a headache diary for headache sufferers that was founded in 2020 following a clinical pilot study at Tartu University Hospital and launched on the App Store and Google Play in 2021. Its team comprises a team of medical experts who have collectively improved the life quality of over 1 billion migraine patients. Over the past two years, Migrevention has raised almost €700,000 in grants and investments, kicked off a study of 600 patients, educated over 2,000 headache patients and 300 primary care specialists, and became Estonia’s first software-based medical device manufacturer.

Proving to be a success story in the digital medicine field, Migrevention is on track towards a future of exponential growth, including a regulatory roadmap for a US roll-out and the FDA processing of the first-generation device in 2023 and the introduction of a second-generation device in 2024.

Katrina Laks, founder and CEO of Migrevention, said: “Our solution allows us to help 10 times more headache patients, thus offering a future treatment option to anyone suffering from frequent migraine headaches. We are developing a solution that would allow us to monitor and prevent headache episodes, as well as offer treatment based on science-based recommendations.”

Triumf Health
Triumf Health has developed an evidence-based digital therapeutics platform for children to deliver personalized psychological support through a game environment. The game, Triumf Hero, guides children through a fun journey through Triumfland to empower them and teach them skills to build resilience. The interactive game environment is used to put theories of emotions, coping, problem-solving, activity-based learning, behaviour change techniques and psychotherapeutic methodology to practical use.

Triumf Hero has won multiple national and international awards, including in the Health and Wellbeing category at the prestigious World Summit Award, which Triumf Health will receive during the 2023 WSA Global Congress, an international networking and learning event for those interested in the use of digital technology to achieve the UN SDGs. Triumf Health was also selected as one of the participants at the Innov8 Talks 2023 pitching competition in the well-being round during the Arab Health Exhibition. The Triumf Hero game is for children aged 7-12 and can be used on any mobile device, such as a tablet or a smartphone.

Dr Kadri Haljas, founder and CEO of Triumf Health, said: “We want to help kids realize their potential. The negative effects of COVID, among other global challenges, were difficult for children to deal with; though they are not born resilient, they are born with the capacity to become resilient. This is where Triumf Hero comes in. Kids all over the world can quickly download the game and embark on an adventure that will empower them to explore their resilience and nurture it for a brighter and stronger future.”

Estonia showcased both companies during Expo 2020’s Health & Wellness week, attracting wide interest from UAE healthcare stakeholders and establishing a nurturing ground for future collaboration. The main collaboration topics that Estonia’s innovations in health addressed were genomics and the use of genetic data in healthcare and digital health data use and implementation. As a result, Triumf Health secured a distribution partner last summer, Diginova Health, to represent it in the GCC, while Migrevention has found a great and forward-thinking partner in King’s University

Hospital in Dubai, where a proof-of-concept trial for headache patients is currently being planned.
Estonia is no stranger to futuristic innovation and technological accomplishments. The country has proclaimed itself a champion of e-governance, a position it endeavours to reciprocate through collaborations with other countries.